759 related articles for article (PubMed ID: 15123022)
1. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y delays hippocampal kindling in the rat.
Reibel S; Benmaamar R; Lê BT; Larmet Y; Kalra SP; Marescaux C; Depaulis A
Hippocampus; 2003; 13(5):557-60. PubMed ID: 12921346
[TBL] [Abstract][Full Text] [Related]
3. Gene expression in the neuropeptide Y system during ethanol withdrawal kindling in rats.
Olling JD; Ulrichsen J; Correll M; Woldbye DP
Alcohol Clin Exp Res; 2010 Mar; 34(3):462-70. PubMed ID: 20028355
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression.
Bjørnebekk A; Mathé AA; Brené S
Hippocampus; 2010 Jul; 20(7):820-8. PubMed ID: 19623606
[TBL] [Abstract][Full Text] [Related]
5. Seizure susceptibility of neuropeptide-Y null mutant mice in amygdala kindling and chemical-induced seizure models.
Shannon HE; Yang L
Epilepsy Res; 2004; 61(1-3):49-62. PubMed ID: 15451008
[TBL] [Abstract][Full Text] [Related]
6. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
7. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
8. CCK-8 prevents the development of kindling and regulates the GABA and NPY expression in the hippocampus of pentylenetetrazole (PTZ)-treated adult rats.
Tirassa P; Costa N; Aloe L
Neuropharmacology; 2005 Apr; 48(5):732-42. PubMed ID: 15814107
[TBL] [Abstract][Full Text] [Related]
9. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of mRNAs for neuropeptide Y and its receptor subtypes in widespread areas of the rat limbic system during kindling epileptogenesis.
Kopp J; Nanobashvili A; Kokaia Z; Lindvall O; Hökfelt T
Brain Res Mol Brain Res; 1999 Sep; 72(1):17-29. PubMed ID: 10521595
[TBL] [Abstract][Full Text] [Related]
11. Changes of brain neuropeptide Y and its receptors in rats with flurazepam tolerance and dependence.
Zhang LP; Wang L
Acta Pharmacol Sin; 2005 Nov; 26(11):1290-6. PubMed ID: 16225749
[TBL] [Abstract][Full Text] [Related]
12. Y5 neuropeptide Y receptor overexpression in mice neither affects anxiety- and depression-like behaviours nor seizures but confers moderate hyperactivity.
Olesen MV; Christiansen SH; Gøtzsche CR; Holst B; Kokaia M; Woldbye DP
Neuropeptides; 2012 Apr; 46(2):71-9. PubMed ID: 22342800
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y Y5 receptors inhibit kindling acquisition in rats.
Benmaamar R; Richichi C; Gobbi M; Daniels AJ; Beck-Sickinger AG; Vezzani A
Regul Pept; 2005 Feb; 125(1-3):79-83. PubMed ID: 15582717
[TBL] [Abstract][Full Text] [Related]
15. Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy.
Rodi D; Mazzuferi M; Bregola G; Dumont Y; Fournier A; Quirion R; Simonato M
Synapse; 2003 Aug; 49(2):116-24. PubMed ID: 12740867
[TBL] [Abstract][Full Text] [Related]
16. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.
St-Pierre JA; Dumont Y; Nouel D; Herzog H; Hamel E; Quirion R
Br J Pharmacol; 1998 Jan; 123(2):183-94. PubMed ID: 9489605
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
Klitgaard H
Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
[TBL] [Abstract][Full Text] [Related]
18. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures.
Gøtzsche CR; Nikitidou L; Sørensen AT; Olesen MV; Sørensen G; Christiansen SH; Ängehagen M; Woldbye DP; Kokaia M
Neurobiol Dis; 2012 Jan; 45(1):288-96. PubMed ID: 21884793
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
20. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
